The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab Letter uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Lymphoma, Non-Hodgkin

publication date

  • January 2019

Research

keywords

  • Letter

Identity

Digital Object Identifier (DOI)

  • 10.1038/s41375-019-0533-6